Indications
Open Access TIMES Journals
Login
Register
Login
Register
Indications
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Open Access TIMES Journals
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Gynecology · Urology
Case Reports
Expert Opinions
Webinar
Faculty
Homepage
>
Gynecology · Urology
>
Articles
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Uro-Oncology
Share:
Related content
HPV and Gynecologic Cancer
Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
Br J Cancer.
Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J
doi: 10.1038/s41416-018-0053-6.
HPV and Gynecologic Cancer
Genetic variations in human papillomavirus and cervical cancer outcomes
Int J Cancer.
Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ
doi: 10.1002/ijc.32038.
Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years
Eur Urol Focus.
Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI
doi: 10.1016/j.euf.2018.01.007.
HPV and Gynecologic Cancer
Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing
Cancer Epidemiol Biomarkers Prev.
Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S
doi: 10.1158/1055-9965.EPI-20-0190.
RECOMMENDED
Pregnancy and Childbirth
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials
Cancer.
Lambertini M, Martel S, Campbell C, Guillaume S, Hilbers FS, Schuehly U, Korde L, Azim HA, Jr, Di Cosimo S, Tenglin RC, Huober J, Baselga J, Moreno-Aspitia A, Piccart-Gebhart M, Gelber RD, de Azambuja E, Ignatiadis M
doi: 10.1002/cncr.31784.
HPV and Gynecologic Cancer
Quantitative methylation analysis of human papillomavirus 16L1 gene reveals potential biomarker for cervical cancer progression
Diagn Microbiol Infect Dis.
Chaiwongkot A, Niruthisard S, Kitkumthorn N, Bhattarakosol P
doi: 10.1016/
Loss of Bcl-2 immunohistochemical expression in endometrial hyperplasia: a specific marker of precancer and novel indication for treatment. A systematic review and meta-analysis
Acta Obstet Gynecol Scand.
Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, De Placido G, Zullo F
doi: 10.1111/aogs.13452.
Uro-Oncology
Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel
Eur Urol Focus.
Hevia V, Boissier R, Rodríguez-Faba Ó, Fraser-Taylor C, Hassan-Zakri R, Lledo E, Regele H, Buddde K, Figueiredo A, Olsburgh J, Breda A
doi: 10.1016/j.euf.2018.05.010.
HPV and Gynecologic Cancer
Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies
Cancer Epidemiol Biomarkers Prev.
Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJ, Kirkpatrick CJ, Kölbl H, Blettner M, Klug SJ
doi: 10.1158/1055-9965.EPI-20-1003.